Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories is well positioned because it is expanding higher-royalty offerings like Atmos and Vision, which lift revenue per device and support a stated 15-20% growth outlook for that business line over the next few years. Its growth profile is becoming more resilient as Atmos Auto has reached 40 OEMs across 140 models, Atmos/Vision/Patents have risen from 23% of license revenue in FY21 to nearly 50%, and VDP and OptiView could add device-independent revenue from streamers and sports customers. Strong cash generation, a $1.44 annual dividend yielding 2.7%, and $150 million remaining on repurchase authorization reinforce the positive outlook even as the core foundational business remains tied to a still-challenged macro environment.

Dolby Laboratories is facing a negative outlook because its revenue is highly exposed to customer device shipment forecasting, and supply chain interruptions make that visibility weaker and less reliable. Semiconductor shortages can inhibit the company’s ability to attach its technology to new devices, while soft device volume trends since the pandemic-related buying boost have pressured foundational revenues and created quarterly lumpiness around OEM renewals. Although Atmos, Vision, and Imaging patents may support growth, the business still depends heavily on licensing and device adoption, leaving near-term fundamentals vulnerable to macro headwinds and chip constraints.